DepYmed Inc.

FARMINGDALE, NY · Biotech · Private

Small molecule inhibitors of PTP1B enzyme for therapeutic treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · depymed.com

Sector: Biotech
Headquarters: FARMINGDALE, NY
Latest Form D: $250K, Apr 2025
Total capital: $9.2M

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: $9.2M; 6 Form D · last Apr 2025; 18 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 3; 4 pending · first 2022; Rank in peer group#339 of 1449

Capital timeline

Latest events

Apr 2025Private capital raisedForm D · SEC · 6th filing$250K
Feb 2025Private capital raisedForm D · SEC · 5th filing$250K
Aug 2024Private capital raisedForm D · SEC · 4th filing$600K
Mar 2024Private capital raisedForm D · SEC · 3rd filing$500K
May 2023Private capital raisedForm D · SEC · 2nd filing$2M
Apr 2021Private capital raisedForm D · SEC · 1st filing$5.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

Granted patents#339 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Andreas G. GrillExecutive Officer, DirectorNamed in SEC Form D filings
Leo G. GuthartDirectorNamed in SEC Form D filings
Peter G. Van NessExecutive OfficerNamed in SEC Form D filings
Peter G. YoungDirectorNamed in SEC Form D filings
Samuel G. BackenrothDirectorNamed in SEC Form D filings
Shankar G. HariharanDirectorNamed in SEC Form D filings

Show all 7 people

Steve G. WinickDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 7

Feb 4, 2025Granted(pyridinylmethyl)butanediamine Derivatives That Chelate CopperUSPTOUS 12,215,128
Jan 2, 2025PendingAminosteroids for the Treatment of a PTP1B Associated DiseaseUSPTOApplication 18425572
Dec 31, 2024GrantedMethod And Compositions For Forming A Copper-containing Complex And Uses ThereofUSPTOUS 12,178,825

Show all 7 patent records

(pyridinylmethyl)butanediamine Derivatives That Chelate CopperFeb 4, 2025 · US 12,215,128Granted
Aminosteroids for the Treatment of a PTP1B Associated DiseaseJan 2, 2025 · Application 18425572Pending
Method And Compositions For Forming A Copper-containing Complex And Uses ThereofDec 31, 2024 · US 12,178,825Granted
Aminosteroids for the Treatment of a PTP1B Associated DiseaseJun 29, 2023 · Application 17877498Pending
Method And Compositions For Forming A Copper-containing Complex And Uses ThereofAug 9, 2022 · US 11,406,647Granted
(pyridinylmethyl)butanediamine Derivatives That Chelate CopperApplication PCTUS2019042580Pending
Method And Compositions For Forming A Copper-containing Complex And Uses ThereofApplication PCTUS2018059450Pending

Scienture Inc.Similar federal contract value in Biotech · null in contracts
LABGENIUS LtdSimilar federal contract value in Biotech · null in contracts
OmniAb, Inc.Similar federal contract value in Biotech · null in contracts
SmartCells, IncSimilar federal contract value in Biotech · null in contracts
Halodine LLCSimilar federal contract value in Biotech · null in contracts
Osmol TherapeuticsSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.